Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 4,353,179 $ 17,787,159
Restricted certificate of deposit 250,375 250,375
Short-term investments 4,959,263
Accounts receivable, net 1,302,494 1,622,434
Inventories 12,536,004 6,666,912
Contract assets 611,236 573,895
Prepaid expenses 6,121,038 5,046,599
Other current assets 53,605 56,410
Total Current assets 25,227,931 36,963,047
Property and equipment, net 21,784,483 15,167,367
Operating lease right-of-use asset 1,384,779 317,208
Other assets 129,370 155,490
Total assets 48,526,563 52,603,112
Current Liabilities:    
Accounts payable 5,731,767 324,484
Accrued liabilities 7,310,051 3,142,977
Operating lease liabilities - current 524,279 410,158
Total Current Liabilities 13,566,097 3,877,619
Warrant liabilities 5,847,057 32,688,342
Operating lease liabilities - long-term 992,660 87,214
Notes payable - long-term, net of discount 17,800,494 15,922,118
Total Liabilities 38,206,308 52,575,293
Commitments and Contingencies
Stockholders’ Equity:    
Common stock, $0.0001 par value; 625,000,000 shares authorized, 47,894,251 and 47,250,771 shares issued, respectively, and 47,894,251 and 47,250,771 shares outstanding, respectively 4,789 4,725
Additional paid-in capital 71,885,793 68,128,196
Accumulated deficit (61,570,327) (68,105,102)
Total Stockholders’ Equity 10,320,255 27,819
Total Liabilities and Stockholders’ Equity $ 48,526,563 $ 52,603,112